PCOS Has a New Name — and It Finally Tells the Truth

If you've ever been told "your ultrasound looks fine, so you don't have PCOS" — and walked away still feeling like something was wrong — this article is for you.

On May 12, 2026, a landmark study published in The Lancet officially changed the name of polycystic ovary syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome, or PMOS. It's not just a rebrand. It's a long-overdue correction to a name that has been misleading patients and providers for decades — and it has real consequences for how this condition is recognized, diagnosed, and treated.

Let's break down what this means for you.

A Name That Never Fit

The term "polycystic ovary syndrome" was coined in the 1930s, based on the observation that some women's ovaries appeared to have multiple cysts on ultrasound. The problem? Those aren't actually cysts. They're small fluid-filled follicles — a sign of disrupted ovulation — and plenty of women with PCOS never had them at all.

Even more importantly, framing this as a condition of the ovaries caused everyone — patients, providers, and researchers alike — to focus on the wrong thing. What was being missed was the bigger picture: a complex, whole-body hormonal and metabolic disorder that affects the reproductive system, yes, but also the cardiovascular system, the skin, mental health, blood sugar regulation, and long-term metabolic risk.

As Dr. Rekha Kumar, endocrinologist at NewYork-Presbyterian/Weill Cornell Medical Center, put it: "This is not a condition defined by ovarian cysts. It is a complex, multisystem hormonal disorder."

The old name led to delayed diagnoses, fragmented care, undertreated metabolic risk, and — for far too many women — the experience of being dismissed.

What PMOS Actually Means

The new name was chosen deliberately, and every word matters:

• Poly-endocrine — This condition involves multiple hormonal systems. We're talking about insulin dysregulation, elevated androgens (like testosterone), imbalances in LH and FSH, and disrupted signaling across the entire endocrine axis. It's not a single-hormone problem.

• Metabolic — Insulin resistance is present in the majority of women with PMOS — including women who are lean or of normal weight. This drives elevated blood sugar risk, abnormal cholesterol patterns, elevated blood pressure, and significantly increased risk for type 2 diabetes and cardiovascular disease over a lifetime.

• Ovarian — The ovaries are still involved. Disrupted ovulation, irregular cycles, and ovarian morphology on ultrasound remain part of the diagnostic picture. But ovarian is now one component of a larger story, not the headline.

Together, the new name reflects what the science has been telling us for years: PMOS is a systemic condition rooted in hormonal and metabolic dysregulation, not a gynecological quirk defined by what shows up on a pelvic ultrasound.

How We Got Here

This name change didn't happen overnight. According to The Lancet, it was the result of a 14-year global consensus process involving:

• Over 22,000 doctors, researchers, patients, and advocates worldwide

• Input from more than 14,300 people living with the condition

• Collaboration across 56 major academic, clinical, and patient organizations

• Endorsement by the Endocrine Society, the Society for Endocrinology, the European Medical Journal, and dozens of others

The announcement was made at the European Congress of Endocrinology in Prague. A three-year transition period is now underway, and PMOS will be fully incorporated into the 2028 International Disease Classification and updated clinical guidelines.

The New York Times noted that the previous name "led to delayed diagnoses, disjointed care, and stigma, while also hindering research and the development of policies." The bar was deliberately set high because, as the research team emphasized, accuracy was prioritized over convenience.

Who This Affects

PMOS affects 1 in 8 women — that's more than 170 million women worldwide (Endocrine Society). It typically becomes apparent in the reproductive years, but its consequences — metabolic syndrome, cardiovascular risk, type 2 diabetes, mood disorders — extend well into midlife and beyond.

If you're a woman in your 30s, 40s, or 50s, you may have been living with this condition for years without a clear diagnosis, or with a diagnosis that only addressed one piece of the puzzle.

Signs that PMOS may be part of your story include:

• Irregular or absent periods, or a history of skipping cycles

• Excess androgen signs: unexplained acne in adulthood, facial or body hair growth, thinning hair on your scalp

• Difficulty with weight, particularly around the midsection, despite reasonable diet and exercise

• Insulin resistance or pre-diabetes on labs, even without obesity

• Fatigue, brain fog, or mood instability that doesn't resolve with sleep

• Elevated triglycerides, low HDL, or other cardiometabolic risk markers

• A history of fertility challenges

You do not need an abnormal ultrasound to have PMOS. A diagnosis requires two out of three criteria: irregular ovulation, signs of excess androgen, or ovarian morphology on ultrasound — and in practice, the most clinically important feature is often the one least talked about: insulin resistance.

Why This Matters Differently in Midlife

For women in perimenopause and menopause, the intersection of PMOS and hormonal transition is particularly important to understand.

As estrogen and progesterone fluctuate and decline, insulin sensitivity worsens. Women who had subclinical or well-managed PMOS in their younger years may find that their metabolic picture shifts — weight becomes harder to manage, blood sugar trends upward, and cardiovascular risk increases. If the underlying metabolic dysregulation was never fully addressed, midlife hormonal change can amplify it significantly.

This is not a reason for panic. It is a reason to be proactive, get the right labs, and work with a provider who understands the full picture — including hormonal and metabolic health together, not in isolation.

What a Proper Workup Looks Like

If you've never had a thorough evaluation — or if your past workup focused only on fertility or symptom management — here's what a comprehensive PMOS assessment should include (NewYork-Presbyterian):

• Detailed menstrual and hormonal history

• Fasting insulin and fasting glucose (not just A1c — fasting insulin is often elevated long before glucose becomes abnormal)

• Serum androgens: total and free testosterone, DHEA-S, SHBG

• Full lipid panel with triglycerides and HDL

• Blood pressure assessment

• Pelvic ultrasound, as one piece — not the only piece — of the diagnostic picture

• Thyroid function, to exclude other contributors to irregular cycles and metabolic symptoms

This is the kind of medicine that gets to the root. Not "your ultrasound looks fine, see you next year."

What Treatment Looks Like When You Get It Right

When PMOS is approached as the metabolic condition it actually is, treatment becomes far more comprehensive — and far more effective.

At Attuned Direct Care, this is how we've always approached hormonal and metabolic health. The name PMOS finally matches the clinical framework we use.

Evidence-based approaches include:

• Lifestyle medicine: nutrition strategies that target insulin resistance, resistance training, sleep optimization, and stress regulation — these are foundational, not optional

• Nutritional support: certain micronutrients, including inositol, magnesium, vitamin D, and omega-3 fatty acids, have meaningful clinical evidence in PMOS management

• Medication when indicated: metformin has long been a tool for insulin sensitization in this population; GLP-1 receptor agonists are emerging as a significant option, showing real promise not only for metabolic improvement but for optimizing hormonal balance and fertility outcomes

• Hormonal support: addressing estrogen and progesterone in the context of perimenopause or menopause, where appropriate

• Mental health integration: anxiety and depression are well-established features of PMOS, not coincidental findings, and should be addressed as part of the whole picture

The goal is not symptom management in silos. It's understanding the underlying physiology — and treating the whole person.

What You Can Do Right Now

Whether you have a PCOS/PMOS diagnosis already or have wondered for years if something hormonal or metabolic has been driving your symptoms, here's where to start:

1. Ask for the right labs. Fasting insulin, a full androgen panel, and a comprehensive metabolic workup are your starting point — not just a pelvic ultrasound.

2. Don't accept "everything looks normal" if you don't feel normal. PMOS is frequently missed in lean women, in women without obvious androgen signs, and in women who haven't been actively trying to conceive.

3. Look at the full picture. Hormonal health, metabolic health, cardiovascular risk, mental health, and reproductive function are all connected. Your care should reflect that.

4. Find a provider who thinks this way. This is exactly the kind of medicine Direct Primary Care was designed to deliver — time, depth, and a provider who knows you.

A Final Thought

Naming things accurately matters in medicine. When a condition is named for what it isn't — cysts that aren't really cysts, a syndrome reduced to one organ when it affects many — the consequences are real. Women go undiagnosed for years. Metabolic risk accumulates quietly. Providers treat the surface without addressing the root.

PMOS is a step toward getting this right. And for the millions of women living with this condition, that step is long overdue.

If you'd like to explore whether PMOS may be part of your health picture, reach out to us at Attuned Direct Care. We'll take the time to look at the whole picture — because that's the only way to actually help.